Clariane Stock Rebounds Over 2% and Defies a Red Market
The personal services group regains momentum on Thursday, reversing the pressure that weighed on the stock in previous sessions. This rebound occurs in a slightly declining European market, making Clariane's movement all the more visible within its benchmark index.
A 2.2% Rebound That Brings the Stock Back to Contact with Its 20-Day Moving Average
Clariane gains 2.2% during the session at €3.99, after giving up ground the previous day and approaching its 200-day moving average at €3.91. The stock is now in contact with its MA20 at €4.00, a gap of only 0.25%. This is a threshold that the stock has struggled to breach sustainably for several weeks, as it remains below its MA50 at €4.03, a gap of nearly 1%.
The next resistance level to watch is at €4.13, while the €3.80 support has not been challenged. The RSI at 43 remains in neutral territory, with no overbought signal that would weaken this rebound. Emeis, a direct comparable in the sector, is also advancing 2.43% during the session, illustrating a positive movement shared by personal care stocks on Thursday, amid a decline in the VIX to 15.41 from 16.34 the previous day.
A Challenging Macro Context and Valuation to Monitor for the Current Fiscal Year
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
The European market is trading in the red on Thursday, with the CAC 40 down 0.26% and the SBF 120 losing 0.15% during the session, weighed down by rising sovereign bond yields and geopolitical tensions in the Gulf, where Brent prices have crossed $95 per barrel. These factors are overall pressuring high-debt companies with regular revenue models, a category in which Clariane falls. The group had issued a senior bond of €500 million maturing in 2031, announced during the publication of its Q1 2026 results on April 23, an operation aimed at securing its financing in a high interest rate environment.
On the valuation front, according to analyst consensus, the stock is trading at approximately 36 times expected earnings for the current fiscal year, a multiple that contrasts with 14 times earnings for the following year, reflecting anticipated strong profit growth over the medium term. Over one year, the stock's performance remains virtually flat at -0.15%, a sign that the stock is consolidating following the financial restructuring undertaken in 2025.
SectorServices et infrastructure de santé›Etablissements de santé / EHPAD
Free · every morning · before 9am
Never miss a move on your stocks
The trend behind the prices · Euronext
✓ You're in! Check your spam folder.
An error occurred.
Context
Period
Period: S1 2026
Key reported figures
Revenue: 2 699 millions d'euros
Quarterly revenue: 2 699 millions d'euros
Revenue growth: 1,6 %
EBITDA: 524 millions d'euros
EBITDA margin: 10,4 %
Net income: -47,5 millions d'euros
Free cash flow: 20 millions d'euros
3 020 millions d'euros
Guidance from the release
Le Groupe s'appuiera principalement sur la poursuite de l'amélioration de la performance opérationnelle et le maintien d'une stricte discipline d'investissements
Risks mentioned
Environnement géopolitique complexe affectant les opérations de refinancement
Exposition aux épisodes climatiques frappant durement certains territoires en Europe
Pression inflationniste continue sur les coûts opérationnels malgré les gains tarifaires
Opportunities identified
Amélioration de la marge EBITDA de 100-150 points de base d'ici fin 2026
Croissance des volumes d'activité portée par l'augmentation progressive des taux d'occupation
Refinancement réussi de €1 063m renforçant la flexibilité financière et réduisant le coût de la dette
Outlook / guidance
Expected revenue: 5 522 millions d'euros
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
